Taken together, these data demonstrate that KAT6A‐induced acetylation of SMAD3 promoted metastasis not only by enhancing breast cancer stem‐like cell properties but also by inducing the MDSCs recruitment by persistent production of immune response‐related cytokines. Here, SMAD3 is linked to breast carcinoma.